Key result
Arrhythmogenic E7K mutation enhances TRPM4 reactivation potency by PIP2 ~40% vs. wild type.
Why the study?
A gain-of-function E7K mutation in the human TRPM4 channel was found to be arrhythmogenic via enhanced membrane expression, prompting investigation of its functional properties compared with wild type.
The arrhythmogenic E7K mutation in the TRPM4 channel abnormally strengthens its interaction with endogenous PIP2, which modulates voltage-dependent activation and may account for its arrhythmogenic potential.
May explain E7K arrhythmogenicity via PIP2; hypothesis-generating for human TRPM4-targeted therapies.
A Ca2+-activated monovalent cation-selective TRPM4 channel is abundantly expressed in the heart. Recently, a single gain-of-function mutation identified in the distal N-terminus of the human TRPM4 channel (Glu5 to Lys5; E7K) was found to be arrhythmogenic because of enhanced cell membrane expression. In this study, we conducted detailed analyses of this mutant channel from more functional aspects, in comparison with its wild type (WT). In an expression system, intracellular application of a short soluble PIP2 (diC8PIP2) restored the single-channel activities of both WT and E7K, which had quickly faded after membrane excision. The potency (Kd) of diC8PIP2 for this recovery was stronger in E7K than its WT (1.44 vs. 2.40 μM). FRET-based PIP2 measurements combined with the Danio rerio voltage-sensing phosphatase (DrVSP) and patch clamping revealed that lowering the endogenous PIP2 level by DrVSP activation reduced the TRPM4 channel activity. This effect was less prominent in E7K than its WT (apparent Kd values estimated from DrVSP-mediated PIP2 depletion: 0.97 and 1.06 μM, respectively), being associated with the differential PIP2-mediated modulation of voltage dependence. Moreover, intracellular perfusion of short N-terminal polypeptides containing either the ‘WT’ or ‘E7K’ sequences respectively attenuated the TRPM4 channel activation at whole-cell and single-channel levels, but in both configurations, the E7K polypeptide exerted greater inhibitory effects. These results collectively suggest that N-terminal interaction with endogenous PIP2 is essential for the TRPM4 channel to function, the extent of which may be abnormally strengthened by the E7K mutation through modulating voltage-dependent activation. The altered PIP2 interaction may account for the arrhythmogenic potential of this mutation.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2021) studied Cardiac arrhythmias. E7K mutation in TRPM4 channel vs. Wild-type (WT) TRPM4 channel was evaluated on Reactivation potency (Kd) of TRPM4 channels by diC8PIP2 after membrane excision. The arrhythmogenic E7K mutation enhances the TRPM4 channel's interaction with PIP2, demonstrating a stronger reactivation potency (Kd 1.44 vs. 2.40 μM) compared to the wild-type channel.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: